Gating with limbic-cortical circuits and its alteration in a developmental disruption model of schizophrenia

Clinical Neuroscience Research

Volumn 3, Issue 4-5, 2003, Pages 333-338

  Grace, Anthony A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Amygdala; Development; Gating; Hippocampus; Nucleus accumbens; Schizophrenia

Indexed keywords

DOPAMINE;

AMYGDALOID NUCLEUS; ANIMAL MODEL; ARTICLE; CHANNEL GATING; COGNITIVE DEFECT; DISORIENTATION; DOPAMINERGIC ACTIVITY; DOPAMINERGIC SYSTEM; EMOTIONALITY; GLOBUS PALLIDUS; LIMBIC CORTEX; NERVE STIMULATION; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SUBICULUM; SYMPTOMATOLOGY; THALAMUS;

EID: 0344899005     PISSN: 15662772     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cnr.2003.10.014     Document Type: Review

References (64)

1. Liddle P.F. Friston K.J. Frith C.D. Hirsch S.R. Jones T. Frachowiak R.S.J. Patterns of cerebral blood flow in schizophrenia Br J Psychiat 160 1992 179-186
2. O'Donnell P. Grace A.A. Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters Schizophrenia Bull 24 1998 267-283
3. Deutch A.Y. Lee M.C. Iadarola M.J. Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: the nucleus accumbens shell as a locus of antipsychotic action Mol Cell Neurosci 3 1992 332-341
4. Angrist B. Santhananthan G. Wilk S. Gershon S. Amphetamine psychosis: behavioral and biochemical aspects J Psychiat Res 11 1974 13-23
5. tAngrist . Rotrosen J. Gershon S. Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia Psychopharmacology 72 1980 17-19
6. Laruelle M. AbiDargham A. Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies J Psychopharmacol 13 4 1999 358-371
7. Laruelle M. The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies Brain Res Rev 31 2000 371-384
8. Creese I. Burt D.R. Snyder S.H. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs Science 192 1976 596-598
9. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia Synapse 1 1987 133-152
10. Grace A.A. Bunney B.S. Moore H. Todd C.L. Dopamine cell depolarization block as a model for the therapeutic actions of antipsychotic drugs Trends Neurosci 20 1997 31-37
11. Onn S.-P. Grace A.A. Repeated treatment with haloperidol and clozapine exerts differential effects on dye coupling between neurons in subregions of striatum and nucleus accumbens J Neurosci 15 1995 7024-7036
12. O'Donnell P. Grace A.A. Differential effects of subchronic clozapine and haloperidol on dye coupling between neurons in the rat striatal complex Neuroscience 66 1995 763-767
13. Chiodo L.A. Bunney B.S. Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons J Neurosci 3 1983 1607-1619
14. White F.J. Wang R.Y. Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons Science 221 1983 1054-1057
15. Eichenbaum H. Is the rodent hippocampus just for 'place'? Curr Opin Neurobiol 6 1996 187-195
16. Robbins T.W. Everitt B.J. Neurobehavioral mechanisms of reward and motivation Curr Opin Neurobiol 6 1996 228-236
17. O'Donnell P. Grace A.A. Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input J Neurosci 15 1995 3622-3639
18. McDonald A.J. Topographical organization of amygdaloid projections to the caudatoputamen, nucleus accumbens, and related striatal-like areas of the rat brain Neuroscience 44 1991 15-33
19. 3H]GABA Neuroscience 22 1987 425-439
20. Fuller T.A. Russchen F.T. Price J.L. Sources of presumptive glutamergic/aspartergic afferents to the rat ventral striatopallidal region J Comp Neurol 258 1987 317-338
21. Grace A.A. Moore H. Regulation of information flow in the nucleus accumbens: a model for the pathophysiology of schizophrenia In: Lenzenweger M.F. Dworkin R.H. editors. Origins and development of schizophrenia: advances in experimental psychopathology 1998 123-157 American Psychological Association Press Washington, DC
22. Legault M. Rompre P.P. Wise R.A. Chemical stimulation of the ventral hippocampus elevates nucleus accumbens dopamine by activating dopaminergic neurons of the ventral tegmental area J Neurosci 20 2000 1635-1642
23. Floresco S.B. Yan C.R. Phillips A.G. Blaha C.D. Basolateral amygdala stimulation evokes glutamate receptor-dependent dopamine efflux in the nucleus accumbens of the anaesthetized rat Eur J Neurosci 10 1998 1241-1251
24. Braff D.L. Grillon C. Geyer M.A. Gating and habituation of the startle reflex in schizophrenic patients Arch Gen Psychiat 49 1992 206-215
25. Caine S.B. Humby T. Robbins T.W. Everitt B.J. Behavioral effects of psychomotor stimulants in rats with dorsal or ventral subiculum lesions: locomotion, cocaine self-administration, and prepulse inhibition of startle Behav Neurosci 115 2001 880-894
26. Weinberger D.R. Gallhofer B. Cognitive function in schizophrenia Int Clin Psychopharmacol Suppl 4 1997 S29-S36
27. Roberts A.C. Robbins T.W. Weiskrantz L. The prefrontal cortex: executive and cognitive functions 1998 Oxford University Press New York
28. Edwards J. Pattison P.E. Jackson H.J. Wales R.J. Facial affect and affective prosody recognition in first-episode schizophrenia Schizophrenia Res 48 2001 235-532
29. Aggleton J.P. The contribution of the amygdala to normal and abnormal emotional states Trends Neurosi 16 1993 328-333
30. Maren S. Neurotoxic or electrolytic lesions of the ventral subiculum produce deficits in the acquisition and expression of Pavlovian fear conditioning in rats Behav Neurosci 113 1999 283-290
31. Grace A.A. Gating of information flow within the limbic system and the pathophysiology of schizophrenia Brain Res Rev 31 2000 330-341
32. Grace A.A. Psychostimulant actions on dopamine and limbic system function: relevance to the pathophysiology and treatment of ADHD In: Solanto M.V. Arnsten A.F.T. Castellanos F.X. editors. Stimulant drugs and ADHD: basic and clinical neuroscience 2001 134-157 Oxford University Press New York
33. Chapman L. Chapman J. Miller G. A theory on verbal behavior in schizophrenia In: Maher B. editor. Progress in experimental personality research I 1964 49-77 Academic Press New York
34. de Silva W.P. Hemsley D.R. The influence of context on language perception in schizophrenia Br J Soc Clin Psychol 16 1977 337-345
35. Javitt D.C. Zukin S.R. Recent advances in the phencyclidine model of schizophrenia Am J Psychiat 148 1991 1301-1308
36. O'Donnell P. Grace A.A. Phencyclidine interferes with the hippocampal gating of nucleus accumbens neuronal activity in vivo Neuroscience 87 1998 823-830
37. Moore H. Grace A.A. Interactions between amygdala and prefrontal cortical afferents to the nucleus accumbens and their modulation by dopamine receptor activation Soc Neurosci Abstr 22 1996-1088
38. Grace A.A. Developmental dysregulation of the dopamine system and the pathophysiology of schizophrenia In: Keshavan M. Kennedy J.L. Murray R.M. editors. Neurodevelopment and schizophrenia 2003 Cambridge University Press Cambridge (in press)
39. West A.R. Grace A.A. Opposite Influences of endogenous dopamine D1 and D2 receptor activation on activity states and electrophysiological properties of striatal neurons: Studies combining in vivo intracellular recordings and reverse microdialysis J Neurosci 22 2002 294-304
40. O'Donnell P. Grace A.A. Dopaminergic reduction of excitability in nucleus accumbens neurons recorded in vitro Neuropsychopharmacology 15 1996 87-97
41. O'Donnell P. Grace A.A. Tonic D2-mediated attenuation of cortical excitation in nucleus accumbens neurons recorded in vitro Brain Res 634 1994 105-112
42. Brown J.R. Arbuthnott G.W. The electrophysiology of dopamine (D2) receptors: a study of the actions of dopamine on corticostriatal transmission Neurosci 10 1983 349-355
43. Flores-Hernandez J. Galarraga E. Bargas J. Dopamine selects glutamatergic inputs to neostriatal neurons Synapse 25 1997 185-195
44. Hsu K.S. Huang C.C. Yang C.H. et al. Presynaptic D2 dopaminergic receptors mediate inhibition of excitatory synaptic transmission in rat neostriatum Brain Res 690 1995 264-268
45. Maura G. Giardi A. Raiteri M. Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals J Pharmacol Exp Ther 247 1988 680-684
46. Yamamoto B.K. Davy S. Dopaminergic modulation of glutamate release in striatum as measured by microdialysis J Neurochem 58 1992 1736-1742
47. Sesack S.R. Aoki C. Pickel V.M. Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets J Neurosci 14 1994 88-106
48. Charara A. Grace A.A. Dopamine modulates excitatory afferents from the hippocampus and amygdala to rat nucleus accumbens neurons recorded in vitro Neuropsychopharmacology 28 2003 1412-1421
49. Susser E. Neugebauer R. Hoek H.W. et al. Schizophrenia after prenatal famine Arch Gen Psychiat 53 1996 2531
50. McDonald C. Murray R.M. Early and late environmental risk factors for schizophrenia Brain Res Rev 31 2000 130-137
51. Pilowsky L.S. Kerwin R.W. Murray R.M. Schizophrenia: a neurodevelopmental perspective Neuropsychopharmacology 9 1993 83-91
52. Lipska B.K. Jaskiw G.E. Weinberger D.R. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal hippocampal damage: a potential animal model of schizophrenia Neuropsychopharmacology 9 1993 67-75
53. Nagata Y. Matsumoto H. Studies on methylazoxymethanol: methylation of nucleic acids in the fetal rat brain Proc Soc Exp Biol Med 132 1969 383-385
54. Bayer S.A. Altman J. Neocortical development 1991 Raven Press New York
55. Moore H. Grace A.A. Anatomical changes in limbic structures produced by methylazoxymethanol acetate (MAM) during brain development are associated with changes in physiological interactions among afferents to the nucleus accumbens Soc Neurosci Abstr 23 1997 2378
56. Edwards H. The significance of brain damage in persistent oral dyskinesia Br J Psychiat 116 1970 271-275
57. Gunne L.M. Growdon J. Glaeser B. Oral dyskinesia in rats following brain lesions and neuroleptic drug administration Psychopharmacology 77 1982 134-139
58. Waddington J.L. Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia Psychopharmacology 101 1990 431-447
59. Kelley A.E. Delfs J.M. Excitatory amino acid receptors mediate the orofacial stereotypy elicited by dopaminergic stimulation of the ventrolateral striatum Neuroscience 60 1994 85-95
60. Kelley A.E. Swanson C.J. Feeding induced by blockade of AMPA and kainate receptors within the ventral striatum: a microinfusion mapping study Behav Brain Res 89 1997 107-113
61. Ghajarnia M. Moore H. Grace A.A. Enhanced behavioral effects of phencyclidine (PCP) in rats with developmental abnormalities of the temporal lobe Soc Neurosci Abstr 24 1998 2177
62. Moore H. Ghajarnia M. Geyer M. Jentsch J.D. Grace A.A. Selective disruption of prefrontal and limbic corticostriatal circuits by prenatal exposure to the DNA methylation agent methylazoxymethanol acetate (MAM): anatomical, neurophysiological and behavioral studies Schizophrenia Res 49 Suppl. 1-2 2001 48
63. Flagstad P, Grace AA, Moore H. Disruption of cerebral cortical development leads to an age-dependent hyper-sensitivity to amphetamine in the rat. Program No. 400.18, 2002. Washington, DC: Society for Neuroscience.
64. Harrison P.J. The neuropathology of schizophrenia. A critical review of the data and their interpretation Brain 122 1999 593-624